Satellos Bioscience Inc. (MSCLF)
OTCMKTS · Delayed Price · Currency is USD
0.4596
+0.0246 (5.66%)
Sep 2, 2025, 12:03 PM EDT
Satellos Bioscience Employees
As of December 31, 2024, Satellos Bioscience had 17 total employees, including 14 full-time and 3 part-time employees. The number of employees increased by 1 or 6.25% compared to the previous year.
Employees
17
Change (1Y)
1
Growth (1Y)
6.25%
Revenue / Employee
n/a
Profits / Employee
-$1,424,847
Market Cap
79.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17 | 1 | 6.25% |
| Dec 31, 2023 | 16 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Satellos Bioscience News
- 12 days ago - Satellos to Participate in Four September Institutional and Retail Investor Conferences - Business Wire
- 20 days ago - Satellos Reports Second Quarter 2025 Results and Highlights Upcoming Clinical Milestones - Business Wire
- 4 weeks ago - Satellos to Present at Canaccord Genuity's 45th Annual Growth Conference - Business Wire
- 2 months ago - Satellos Bioscience Shareholders Elect Two New Board Members - Business Wire
- 2 months ago - Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders - Business Wire
- 2 months ago - Satellos Bioscience to Participate in PPMD's Annual Conference in Las Vegas - Business Wire
- 3 months ago - Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy - Business Wire
- 3 months ago - Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants - Newsfile Corp